Jpmorgan Chase & CO Clear Point Neuro, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 9,770 shares of CLPT stock, worth $153,486. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,770
Previous 6,158
58.66%
Holding current value
$153,486
Previous $33,000
230.3%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Vanguard Group Inc Valley Forge, PA1.24MShares$19.5 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA464KShares$7.29 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.89 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.76 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$5.24 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $385M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...